Home / Amoxicillin and Beta-Lactamase Inhibitor / Switzerland
CH ATC J01CR02 · updated 2 Nov 2026
Amoxicillin and Beta-Lactamase Inhibitor shortage in Switzerland
Is there an Amoxicillin and Beta-Lactamase Inhibitor shortage in Switzerland?
Yes. As of 2 Nov 2026, 2 Amoxicillin and Beta-Lactamase Inhibitor products are reported short in Switzerland, the first since 7 Aug 2026. The company estimate for the return is 1 Feb 2027. Main reason: not stated.
Also short in Canada, Italy, Spain, Ireland, Czechia, Sweden. All countries.
Affected products in Switzerland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | CO-AMOXICILLIN Labatec Trockensub 1.2 g 10 Stk | Labatec Pharma SA | 7 Aug 2026 | 1 Feb 2027 | Not stated |
| CH | CO-AMOXI Mepha Trockensub 1100 mg Durchstf 10 Stk | Mepha Pharma AG | 30 Sep 2026 | not given | Not stated |
Source
FONES (Federal Office for National Economic Supply), reporting office for vital medicines. Official list. Vital human medicines only (the federal list of reportable active substances); one row per pack (GTIN).